SCHEMBL5242249

SCHEMBL5242249

CC(C)OC(C)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL199302 0.82
SCHEMBL10962700 0.75
SCHEMBL8467498 0.75
SCHEMBL6238591 0.72
SCHEMBL1331944 0.71
SCHEMBL10940023 0.71
SCHEMBL1296 0.71
SCHEMBL7240952 0.71
SCHEMBL3361601 0.69
SCHEMBL3390654 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109761761-A A kind of preparation method of ethoxy propylene 山东国邦药业股份有限公司 2019-05-17 CN disclosed
CN-106008234-B The synthetic method of the isopropoxy ethamine of N, N diisopropyl 2 浙江大学 2017-10-31 CN disclosed
EP-1765330-A4 PYRANOINDOLE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION OR DISEASE VIROPHARMA INC (US) 2007-10-17 EP disclosed
EP-1765330-A2 PYRANOINDOLE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION OR DISEASE Viropharma Incorporated (US) 2007-03-28 EP disclosed
WO-2005084315-A2 PYRANOINDOLE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTION OR DISEASE VIROPHARMA INCORPORATED (US) 2005-09-15 WO disclosed